India’s Breaking Bad: Synthetic Drugs Worth At Least Rs 2,300 Crore Seized
The Department of Revenue Intelligence (DRI) has seized 23.5 metric tonne (23,500 kilograms) of mandrax tablets (methaqualone) estimated to be worth between Rs 2,300 crore to Rs 4,000 crore from Udaipur, Rajasthan. Commenting on the seizure, the Central Board of Excise and Customs (CBEC) Chairman Najib Shah said, "This is the largest ever seizure of synthetic drugs in the country." The DRI is the apex counter-smuggling agency of the CBEC.
DRI officers raided the premises of M/s Marudhar Drinks, Bhamasha Industrial Area in Kaladwas, Udaipur on October 28, 2016, according to a press statement released by the agency. The methaqualone warehouse was masquerading as a bottle manufacturing facility, officials said. DRI officials said that the manufacturing facilities were located nearby and the tablets seized were ready for consumption.
Director General of Directorate of Revenue Intelligence (DRI), Jayant Misra told BloombergQuint in an interview that the mastermind has other businesses which links him to the film industry.
The mastermind, Subhash Dudani has been arrested from Mumbai and he has been in the business of DVDs and CDs and has links with Bollywood by virtue of this business.Jayant Misra, Director General, Directorate of Revenue Intelligence
Dudani was also the producer of the 2011 hindi thriller, Vikalp.
When asked about where these drugs could possibly be sold, Misra said, "The countries where they were expected to be headed are Mozambique and South Africa. The India consumption link has not yet been established."
Some of the raw materials used to produce madrax were procured under valid licenses. The press statement noted that one of the raw materials (acetic anhydride) was manufactured by Shreenath Industries in Rajsamand, Rajasthan. The other raw materials needed to produce mandrax tablets are anthranilic acid (which was imported from Indonesia and brought in through the Kandla Port by ‘declaring' it as maleic anhydride), ortho toluidine, phosphorous trichloride, and caustic soda (procured locally).
Commenting on the licensed procurement of raw materials, Misra said, "The precursor chemicals out of which these drugs were manufactured are used in other medicines also, but so far as methaqualone is concerned, it is banned. This was being clandestinely manufactured in the country."
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.